ERK1/2 activation is a therapeutic target in age-related macular degeneration
Journal Article
Overview
publication date
- August 21, 2012
has subject area
- Animals
- Biochemical Phenomena - Enzyme Activation
- Biochemical Phenomena - Phosphorylation
- Biochemical Phenomena - Signal Transduction
- Cell Physiological Phenomena - Signal Transduction
- DEAD-box RNA Helicases
- Enzyme Inhibitors
- Gene Expression Regulation, Enzymologic
- Heterocyclic Compounds, 2-Ring - Flavonoids
- Humans
- Macular Degeneration
- Metabolism - Enzyme Activation
- Metabolism - Phosphorylation
- Mice
- Organic Chemistry Phenomena - Phosphorylation
- Peptides - Mitogen-Activated Protein Kinase 1
- Peptides - Mitogen-Activated Protein Kinase 3
- Protein-Serine-Threonine Kinases - Mitogen-Activated Protein Kinase 1
- Protein-Serine-Threonine Kinases - Mitogen-Activated Protein Kinase 3
- Proteins - Mitogen-Activated Protein Kinase 1
- Proteins - Mitogen-Activated Protein Kinase 3
- Pyrans - Flavonoids
- Retina - Retinal Pigment Epithelium
- Ribonuclease III
- Sense Organs - Retinal Pigment Epithelium
has restriction
- bronze
Date in CU Experts
- October 18, 2013 3:21 AM
Full Author List
- Dridi S; Hirano Y; Tarallo V; Kim Y; Fowler BJ; Ambati BK; Bogdanovich S; Chiodo VA; Hauswirth WW; Kugel JF
author count
- 17
citation count
- 86
published in
Other Profiles
International Standard Serial Number (ISSN)
- 0027-8424
Digital Object Identifier (DOI)
Additional Document Info
start page
- 13781
end page
- 13786
volume
- 109
issue
- 34